Cost?effectiveness of Anti?CD19 chimeric antigen receptor T?Cell therapy in pediatric relapsed/refractory B?cell acute lymphoblastic leukemia. A societal view

Frederick Thielen, A van Dongen-Leunis, AMM Arons, JR Ladestein, PR Hoogerbrugge

Research output: Contribution to journalArticleAcademicpeer-review

13 Citations (Scopus)
2 Downloads (Pure)
Original languageEnglish
JournalEuropean Journal of Haematology
Issue number2
Publication statusPublished - 2020

Cite this